Paul Allan Offit (born March 27, 1951) is an American pediatrician specializing in infectious diseases, vaccines, immunology, and virology. He is the co-inventor of a rotavirus vaccine. Offit is the Maurice R. Hilleman Professor of Vaccinology, professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, former chief of the Division of Infectious Diseases (1992–2014), and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia.

Offit is a member of the Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee and was a member of the Centers for Disease Control (CDC) Advisory Committee on Immunization Practices. Offit is a board member of Every Child By Two and a founding board member of the Autism Science Foundation (ASF).

Paul Offit

Offit has published more than 130 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety, and is the author or co-author of books on vaccines, vaccination, the rejection of medicine by some religious groups, and antibiotics. He is one of the most public faces of the scientific consensus that vaccines have no association with autism. As a result, he has been the frequent target of hate mail and death threats.

Paul Offit

In 2023, he was elected to the American Philosophical Society.

Paul Offit

Life

Offit grew up in Baltimore, the son of a shirtmaker. He went to his father's sales meetings and reacted negatively to the tall tales told by salespeople, instead preferring the clean and straightforward practice of science. When he was five years old, he was sent to a polio ward to recover from clubfoot surgery; this experience caused him to see children as vulnerable and helpless, and motivated him through the 25 years of the development of the rotavirus vaccine.

Offit decided to become a doctor, the first in his family. Offit earned his bachelor's degree from Tufts University and his M.D. from the University of Maryland, Baltimore. In 1980, he completed his residency training in Pediatrics at Children's Hospital of Pittsburgh. That year, he began a fellowship in infectious diseases at Children's Hospital of Philadelphia. One of his mentors was Maurice Hilleman, who developed many of the major vaccines in use today.

In 1990, Offit married Bonnie Fass-Offit, who is also a pediatrician. They had two children.

By 2008 Offit had become a leading advocate of childhood immunizations. He was opposed by vaccine critics, many of whom believe vaccines cause autism, a belief that has been rejected by major medical journals and professional societies. He received a death threat and received protection by an armed guard during meetings at the CDC. His 2008 book Autism's False Prophets catalyzed a backlash against the antivaccine movement in the U.S. He donated the royalties from the book to the Center for Autism Research at Children's Hospital of Philadelphia. Offit served on the board of the American Council on Science and Health until 2015 when he resigned from the group, accusing them of crossing the line for their promotion of e-cigarettes. In 2015, Offit appeared in a vaccine awareness video created by Robert Till in which he advocated teenage vaccinations.

Rotavirus vaccine

Offit worked for 25 years on the development of a safe and effective vaccine against rotavirus, which is a cause of diarrhea, and which kills almost 600,000 children a year worldwide, about half as many as malaria kills; most deaths are outside the West. His interest in the disease stemmed from the death of a 9-month-old infant from rotavirus-caused dehydration while under his care as a pediatric resident in 1979.

Along with his colleagues Fred Clark and Stanley Plotkin, Offit invented RotaTeq, a pentavalent rotavirus vaccine manufactured by Merck & Co. Since 2006, RotaTeq has been one of two vaccines currently used against rotavirus.

In February 2006, RotaTeq was approved for inclusion in the recommended U.S. vaccination schedule, following its approval by the FDA. Premarketing studies found that RotaTeq was effective and safe, with an incidence of adverse events comparable to placebo. RotaTeq has been credited (by Peter Hotez) with saving hundreds of lives a day. Offit received an unspecified sum of money for his interest in RotaTeq. Offit was elected a fellow of the Committee for Skeptical Inquiry, in 2015.